Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomesHeather J. Bax, Debra H. Josephs, Jitesh Chauhan et al.|British Journal of Cancer|2022Cited by 89
Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidateHeather J. Bax, Sophia N. Karagiannis, Atousa Khiabany et al.|Allergy|2020Cited by 22
Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck CancerCharleen Chan Wah Hak, Kevin J. Harrington|Cancer Research Communications|2025Cited by 1
The National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Workshop: Translating Novel Discoveries to and from the ClinicCharleen Chan Wah Hak, Thomas Ward, Shreerang Bhide et al.|Clinical Oncology|2023Cited by 0